Duloxetine Delayed-Release Cap USP 30mg, 30-count bottle, Rx only, Preferred Pharmaceutcals, Inc., NDC 68788-9301-03
Published May 29, 2024 · Recall initiated: May 10, 2024
Summary
FDA records drug Class II recall D-0505-2024, published May 29, 2024 and initiated May 10, 2024. Recalling firm: Preferred Pharmaceuticals, Inc.; Status: Ongoing; Reported quantity: 66 bottles of 30 tablets; Lot: Lot #: J2022G, Exp: 01/01/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Preferred Pharmaceuticals, Inc.
- Distributor
- Product distributed to CA, FL, OK, KS and CT
- Lot
- Lot #: J2022G, Exp: 01/01/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAArtificial Tears Lubricant Eye Drops, Visine, Pkg Size: 15, Mfg: Geri-Care: Brooklyn, NY. NDC: 68788-7266-0November 11, 2026
- FDALidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro PharmaceuticalsOctober 14, 2026
- FDAArtificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene glycol 400 1%), 0.5 ozApril 15, 2026
- FDAOndansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged byDecember 24, 2025
- FDASirolimus Tablets 1mg Tablets 100-count bottle, Rx Only, Distributed by: Dr. Reddy's Laboratories Inc.,May 29, 2024
- FDAHaloperidol decanoate Injection 50mg/mL, packaged in a) 1 mL Single-Dose Vials (NDC 70069-381-01) and b) 10May 29, 2024
Questions about this recall
Was Duloxetine Delayed-Release Cap USP 30mg, 30-count bottle, Rx only, Preferred Pharmaceutcals, Inc., NDC 68788-9301-03 recalled?
Yes. FDA published recall D-0505-2024 on May 29, 2024. Reported hazard: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
What should I do if I have this product?
Voluntary: Firm initiated · Letter